Management of patients with COVID-19
Versandkostenfrei!
Versandfertig in 6-10 Tagen
29,99 €
inkl. MwSt.
PAYBACK Punkte
15 °P sammeln!
COVID-19 is a human-to-human transmission virosis, and in view of the increasing number of cases, home management was adopted as an alternative. The aim of this study was to assess the effectiveness of home care. It was a cross-sectional study nested in an open cohort of 1109 patients. Patients were followed up in hospital and/or at home until two consecutive negative PCR tests 48 hours apart. Males and patients aged between 20 and 40 years were most commonly represented. At the end of the study, 81.2% (900/1109) of patients were cured, 1.3% (14/1109) were transferred to another healthcare fac...
COVID-19 is a human-to-human transmission virosis, and in view of the increasing number of cases, home management was adopted as an alternative. The aim of this study was to assess the effectiveness of home care. It was a cross-sectional study nested in an open cohort of 1109 patients. Patients were followed up in hospital and/or at home until two consecutive negative PCR tests 48 hours apart. Males and patients aged between 20 and 40 years were most commonly represented. At the end of the study, 81.2% (900/1109) of patients were cured, 1.3% (14/1109) were transferred to another healthcare facility and 2.5% (28/1109) died. No significant difference was observed between the median duration of remission of patients at home (95% CI, 9.69-10.31) and those managed in hospital (10 days) in (95% CI, 9.76-10.24) (Log-Rank test, p= 0.066). These results suggest that place of care and gender do not influence remission time, and that home care is effective despite the shortcomings of the information system linking doctor and patient.
Andere Kunden interessierten sich für
